Pharma Industry News
A collection of Pharma latest news, analysis and best practices from top business influencers and the world's most trustworthy sources.
Have $1,000 to Invest? This Dirt Cheap Pharma Stock Pays You 4.2% to Wait.
Bristol Myers Squibb (BMY -1.54%) has one of the highest dividend yields among major pharmaceutical stocks. At current prices, its shares have a forward yield of around 4.2%. However, consider the yield not as the sole reason to buy, but as an…
Why pharma giant Roche is putting German investments on hold
Swiss pharmaceutical giant Roche said on Monday it would put expansion in Germany on hold, dealing a blow to Berlin as a government-backed investment summit got underway. 'We have put all future investment decisions in Germany on hold for the time…
Avalyn Pharma (NASDAQ:AVLN) Reaches New 52-Week Low - Should You Sell?
Avalyn Pharma Inc. (NASDAQ:AVLN - Get Free Report)'s stock price hit a new 52-week low during trading on Tuesday. The stock traded as low as $22.24 and last traded at $23.57, with a volume of 9,188 shares. The stock had previously closed at $23.33.
BridgeBio Pharma (NASDAQ:BBIO) Given New $91.00 Price Target at Citigroup
BridgeBio Pharma (NASDAQ:BBIO - Get Free Report) had its target price reduced by analysts at Citigroup from $94.00 to $91.00 in a report released on Monday, Benzinga reports. The firm currently has a 'neutral' rating on the stock. Citigroup's…
Avalyn Pharma Inc.'s Lock-Up Period Set To End on October 27th (NASDAQ:AVLN)
Avalyn Pharma's (NASDAQ:AVLN - Get Free Report) lock-up period will expire on Tuesday, October 27th. Avalyn Pharma had issued 16,666,667 shares in its public offering on April 30th. The total size of the offering was $300,000,006 based on an…
GLP-1 injections recalled nationwide - what to know about the affected products
An unexpected shot of bad news. A popular weight-loss shot has been recalled across the country by the FDA due to potential contamination. The US-based compounding pharmacy that issued the initial recall back in September had already been on the…
Kevin Warsh's Fed May Not Cut Rates Soon. That's Why This Dividend Stock Belongs in Your Portfolio.
Kevin Warsh's Federal Open Market Committee (FOMC) has its next meeting on Oct. 28 to decide on a course of action for interest rates. It looks as if they aren't coming down anytime soon. According to the CME Group 's proprietary FedWatch tool…
RFK Jr. Blames Measles Outbreak on Missed Vaccinations After Years of Warning About MMR Risks
For years, Robert F. Kennedy Jr. championed families whose children were injured by the measles, mumps, and rubella (MMR) vaccine. He challenged federal health agencies and Big Pharma, popularized censored research, and co-authored a book exposing…
Big Pharma's Body Count: Prescription Drugs Now the Leading Cause of Death, Surpassing Heart Disease and Cancer
A landmark re-analysis of drug mortality data has delivered a verdict the medical establishment has spent decades avoiding: pharmaceuticals have overtaken heart disease and cancer to become the single leading cause of death. Our prescription drugs…
New mission will test making cancer drugs in space
Orbital pharma and re-entry startup Varda Space Industries launched a new mission Tuesday to test microgravity's effects on an innovative cancer treatment. Why it matters: Developing medicine in space, away from the pesky influence of Earth's…
Chronic Hand Eczema (CHE) is affecting NHS healthcare professionals and can impact patient care, report finds
LEO Pharma and the British Skin Foundation (BSF) today launched a new report exploring the impact of Chronic Hand Eczema (CHE) on NHS healthcare professionals (HCPs) and the wider healthcare workforce. CHE is a fluctuating inflammatory skin…
MDMA (Molly) for PTSD: Hope, Hype, and Hard Evidence
A review/meta-analysis found MDMA-assisted therapy improves PTSD symptoms, but evidence certainty is low. Positive trials establish lasting remission, adequate safety, and effectiveness in ordinary clinical practice. VA and independent…
AZ set to move its registered office to Maharashtra, from Karnataka
Multinational drugmaker AstraZeneca Pharma India is set to move its registered office from Karnataka to Maharashtra. Just last week, it unveiled its new corporate office in Mumbai, inaugurated by the Maharashtra Chief Minister. In May, AZ had told…
There's still hope for TotalEnergies as UCI announces team registrations for 2027
The number of men's ProTeams has shrunk by two, but the women's grew by one, and the men's and women's WorldTour teams should all be in the peloton in 2027, as the UCI announced the number of teams that have met the registration deadline of October…
Movistar rider quits team two years early to join influx of Netcompany Ineos signings
Netcompany Ineos have announced that Spanish all-rounder and former WorldTour stage winner Javier Romo has signed with the British team for two years. The rider from Toledo has reached a joint agreement with his current team, Movistar, to end his…
Receive a Daily briefing on Pharma Industry News
Get Started